1-1 of 1
Alice Mohr
Close
Save search
Sort by
Journal Articles

Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL

Free
Clinical Trials & Observations
Pallawi Torka, Adrienne Groman, Jerry Wong, Jenna Nichols, Angela Kader, Cory Mavis, Andrea Anampa-Guzmán, Sheila Jani Sait, AnneMarie Block, Eugene Przespolewski, Alice Mohr, Ian Lund, Kenneth McWhite, Jessica Kostrewa, Joseph DeMarco, Michael Johnson, Andrea Darrall, Roshneke Thomas, Suchitra Sundaram, Paola Ghione, Alan Hutson, Francisco J. Hernandez-Ilizaliturri
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1146–1155.
https://doi.org/10.1182/bloodadvances.2022008543
Published: 2023
Includes: Supplemental data